Key statistics
On Tuesday, Genelux Corp (GNLX:NAQ) closed at 2.56, 28.81% above the 52 week low of 1.99 set on Apr 09, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 2.59 |
|---|---|
| High | 2.68 |
| Low | 2.53 |
| Bid | 2.53 |
| Offer | 2.80 |
| Previous close | 2.61 |
| Average volume | 237.22k |
|---|---|
| Shares outstanding | 44.71m |
| Free float | 39.84m |
| P/E (TTM) | -- |
| Market cap | 116.70m USD |
| EPS (TTM) | -0.8803 USD |
Data delayed at least 15 minutes, as of Feb 17 2026 21:00 GMT.
More ▼
- Genelux Corporation Announces Upcoming Virtual Fireside Chat Hosted by Titan Partners
- Genelux Corporation Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock
- Genelux Corporation Announces Proposed Public Offering of Common Stock
- Genelux Corporation Reports Encouraging Interim Data of Systemic Administration of Olvi-Vec in Ongoing Lung Cancer Trials
- Genelux Corporation Announces Appointment of Jason Litten, M.D., as Chief Medical Officer
- Genelux Corporation to Participate in a Fireside Chat at Piper Sandler 37th Annual Healthcare Conference
- Genelux Corporation Reports Third Quarter 2025 Financial Results and Provides General Business Updates
- Genelux Corporation to Participate in a Fireside Chat at H.C. Wainwright Global Investment Conference
- Genelux Corporation Reports Second Quarter 2025 Financial Results and Provides General Business Updates
- Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development
More ▼
